383 related articles for article (PubMed ID: 19150974)
1. Quality of life in relation to mood, coping strategies, and dyskinesia in Parkinson's disease.
Montel S; Bonnet AM; Bungener C
J Geriatr Psychiatry Neurol; 2009 Jun; 22(2):95-102. PubMed ID: 19150974
[TBL] [Abstract][Full Text] [Related]
2. Coping and quality of life of patients with Parkinson disease who have undergone deep brain stimulation of the subthalamic nucleus.
Montel SR; Bungener C
Surg Neurol; 2009 Aug; 72(2):105-10; discussion 110-1. PubMed ID: 18786708
[TBL] [Abstract][Full Text] [Related]
3. Coping and quality of life in one hundred and thirty five subjects with multiple sclerosis.
Montel SR; Bungener C
Mult Scler; 2007 Apr; 13(3):393-401. PubMed ID: 17439909
[TBL] [Abstract][Full Text] [Related]
4. [Neuropsychiatric problems in patients with Parkinson's disease].
Zhou MZ; Liu ZG; Gan J; Chen W; Lu LX; Wu JY
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(21):1442-5. PubMed ID: 18953846
[TBL] [Abstract][Full Text] [Related]
5. Mood disorders in Parkinson's disease.
Tan LC
Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S74-6. PubMed ID: 22166461
[TBL] [Abstract][Full Text] [Related]
6. Depressive coping is a predictor for emotional distress and poor quality of life in a German-Austrian sample of cardioverter-defibrillator implant recipients at 3 months and 1 year after implantation.
Fritzsche K; Forster F; Schweickhardt A; Kanwischer H; Drinkmann A; Rabung S; Bergmann G; Geibel A; Herrmann-Lingen C
Gen Hosp Psychiatry; 2007; 29(6):526-36. PubMed ID: 18022046
[TBL] [Abstract][Full Text] [Related]
7. Clinical and psychosocial factors associated with fatigue in patients with Parkinson's disease.
Havlikova E; Rosenberger J; Nagyova I; Middel B; Dubayova T; Gdovinova Z; W Groothoff J; P van Dijk J
Parkinsonism Relat Disord; 2008; 14(3):187-92. PubMed ID: 17890136
[TBL] [Abstract][Full Text] [Related]
8. [Assessing quality of life in Parkinson's disease using the PDQ-39. A pilot study].
Martínez-Martín P; Frades Payo B; Fontán Tirado C; Martínez Sarriés FJ; Guerrero MT; del Ser Quijano T
Neurologia; 1997 Feb; 12(2):56-60. PubMed ID: 9147452
[TBL] [Abstract][Full Text] [Related]
9. Young- versus older-onset Parkinson's disease: impact of disease and psychosocial consequences.
Schrag A; Hovris A; Morley D; Quinn N; Jahanshahi M
Mov Disord; 2003 Nov; 18(11):1250-6. PubMed ID: 14639664
[TBL] [Abstract][Full Text] [Related]
10. Depression and self-reported depressive symptoms in multiple system atrophy compared to Parkinson's disease.
Tison F; Yekhlef F; Chrysostome V
Mov Disord; 2006 Jul; 21(7):1056-7. PubMed ID: 16628602
[No Abstract] [Full Text] [Related]
11. Anxiety and depression: main determinants of health-related quality of life in Brazilian patients with Parkinson's disease.
Carod-Artal FJ; Ziomkowski S; Mourão Mesquita H; Martínez-Martin P
Parkinsonism Relat Disord; 2008; 14(2):102-8. PubMed ID: 17719828
[TBL] [Abstract][Full Text] [Related]
12. What relation is there between deep brain stimulation and coping strategies in Parkinson's disease?
Montel S; Bungener C
Mov Disord; 2008 Sep; 23(12):1780-4. PubMed ID: 18661551
[TBL] [Abstract][Full Text] [Related]
13. Effects of ropinirole on nonmotor symptoms of Parkinson disease: a prospective multicenter study.
Rektorova I; Balaz M; Svatova J; Zarubova K; Honig I; Dostal V; Sedlackova S; Nestrasil I; Mastik J; Bares M; Veliskova J; Dusek L
Clin Neuropharmacol; 2008; 31(5):261-6. PubMed ID: 18836343
[TBL] [Abstract][Full Text] [Related]
14. Determinants of disability and quality of life in mild to moderate Parkinson disease.
Muslimovic D; Post B; Speelman JD; Schmand B; de Haan RJ;
Neurology; 2008 Jun; 70(23):2241-7. PubMed ID: 18519873
[TBL] [Abstract][Full Text] [Related]
15. Coping processes and health-related quality of life in Parkinson's disease.
Bucks RS; Cruise KE; Skinner TC; Loftus AM; Barker RA; Thomas MG
Int J Geriatr Psychiatry; 2011 Mar; 26(3):247-55. PubMed ID: 20626049
[TBL] [Abstract][Full Text] [Related]
16. [Validation of CHIP (a coping questionnaire) in French patients with neurological disorders].
Montel S; Bungener C
Rev Neurol (Paris); 2010 Jan; 166(1):54-60. PubMed ID: 19515394
[TBL] [Abstract][Full Text] [Related]
17. Comorbidity in Australia: findings of the 2007 National Survey of Mental Health and Wellbeing.
Teesson M; Slade T; Mills K
Aust N Z J Psychiatry; 2009 Jul; 43(7):606-14. PubMed ID: 19530017
[TBL] [Abstract][Full Text] [Related]
18. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.
Honig H; Antonini A; Martinez-Martin P; Forgacs I; Faye GC; Fox T; Fox K; Mancini F; Canesi M; Odin P; Chaudhuri KR
Mov Disord; 2009 Jul; 24(10):1468-74. PubMed ID: 19425079
[TBL] [Abstract][Full Text] [Related]
19. Individualized assessment of quality of life in idiopathic Parkinson's disease.
Lee MA; Walker RW; Hildreth AJ; Prentice WM
Mov Disord; 2006 Nov; 21(11):1929-34. PubMed ID: 16986143
[TBL] [Abstract][Full Text] [Related]
20. [Rating scales and questionnaires in Parkinson's disease].
Mauduit N; Schück S; Allain H; Chaperon J
Rev Neurol (Paris); 2000; 156 Suppl 2 Pt 2():63-9. PubMed ID: 10916038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
